Shuttle Pharmaceuticals Files 8-K
Ticker: SHPH · Form: 8-K · Filed: Apr 21, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Apr 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
Shuttle Pharma filed an 8-K, likely routine, no major news yet.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on April 21, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material agreements, but serves as a notification of these categories being addressed.
Why It Matters
This filing indicates that Shuttle Pharmaceuticals is making required disclosures to the SEC, which could include updates on financial status or other significant corporate events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K notification without specific material events disclosed, suggesting no immediate new risks.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- April 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What specific "Other Events" are being reported by Shuttle Pharmaceuticals Holdings, Inc. in this 8-K filing?
The filing does not specify the nature of the "Other Events" beyond listing it as an item information category.
Are there any new financial statements or exhibits attached to this 8-K filing?
The filing lists "Financial Statements and Exhibits" as an item information category, but the specific contents are not detailed in the provided text.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported is April 21, 2025.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the Commission File Number for Shuttle Pharmaceuticals Holdings, Inc.?
The Commission File Number for Shuttle Pharmaceuticals Holdings, Inc. is 001-41488.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).